Gemachlich ZuHause ARTHRITIS RELIEF SPRAYS NDC 76986-035

NDC codes

FDA NDC Directory

Product NDC (as listed)76986-035Labeler and product segments. Claims need a package NDC.

Product NDC at billing width76986-0035Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
76986-035-01	76986003501	1 BOTTLE in 1 BOX (76986-035-01) / 60 mL in 1 BOTTLEMarketed from Apr 22, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Gemachlich ZuHause ARTHRITIS RELIEF SPRAYS
Generic name (nonproprietary): arnica montana 1x hpus
Active ingredients: Arnica montana — .07 g/mL
Dosage form: Spray
Route: Topical
Labeler: Guangdong Quadrant Ecological Technology Co., Ltd.
Product type: Over-the-counter drug
Marketing category: Unapproved homeopathic
Marketing start: Apr 22, 2026
Listing expires: Dec 31, 2027
Identifiers: Product ID 76986-035_5007ee42-089b-2f0e-e063-6394a90a1021SPL ID 5007ee42-089b-2f0e-e063-6394a90a1021SPL set ID 5007ee42-089a-2f0e-e063-6394a90a1021UNII O80TY208ZWUPC 6977863765046

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N476986003501 followed by a unit qualifier and the quantity

Package 76986-0035-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 22, 2026.

Indications (excerpt from the label)

Purpose: Promotes local blood circulation, adjunctive therapy for Arthritis, Neuropathy, Tingling,Burning and Numbness. Relieves Muscle Pain, Neuralgia, Stiffness,Swelling, Bruising Symptoms.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)